$TRUP

GALLAGHER JOHN R sold $11K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 431 shares of TRUPANION, INC. (TRUP) at $25.35 on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jul 1, 2026, 11:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 11:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

Confirms the COO reduced holdings by ~$10.9k; typically not a catalyst for re-rating absent additional fundamental news.

02

Market read

Traders may log the sale for sentiment/positioning, but it is unlikely to drive price without corroborating fundamentals.

03

What to watch

The filing does not indicate intent beyond the plan; without context on prior grants/sales cadence, it’s hard to infer directionality.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-01; sale executed 2026-06-29

Background

SEC Form 4 discloses an officer’s open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

TRUP insider filing shows COO John R. Gallagher sold 431 shares at $25.35 on 2026-06-29 under a 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect would be second-order via sentiment rather than fundamentals.

Evidence & confidence

Form 4 is a primary disclosure, but the transaction is explicitly under a pre-arranged 10b5-1 plan and is small relative to typical market moves.

Market effects

No clear sector read-through from a single routine 10b5-1 sale.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may watch for follow-on sales or changes in buying behavior.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction was disclosed on Form 4.

  • GALLAGHER JOHN R

    Chief Operating Officer who sold 431 shares.

  • Rule 10b5-1 plan

    Pre-arranged plan that generally reduces informational content of the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended